<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css">

Welcome to JLUpub

Communities in JLUpub

Select a community to browse its collections.

Now showing 1 - 2 of 2

Recent Submissions

  • Item type:Item,
    Direct comparison of different probe positioning and pointing schemes for plume measurements using an Advanced Cusp Field Thruster
    (2026) Bauer, Leonard; Vaupel, Max; Blättermann, Hans; Sütterlin, Saskia; Kottke, Gerrit; Hey, Franz Georg; Klar, Peter J.
    We investigate how probe positioning and pointing schemes affect ion current density measurements, specifically total beam current and divergence efficiency. Experiments were conducted using a five-axis gantry and a nude Faraday probe in the plume of an Advanced Cusp Field Thruster (ACFT). By mimicking Cartesian and spherical diagnostic geometries, we compare typical measurement strategies within a single setup. Additionally, maximizing local current via probe rotation reconstructs the ion plume origin, revealing a volumetric source shaped by the discharge chamber. While mathematical corrections for rigid probe misalignment exist, uncertainties from collector angle and secondary electron emission grow significantly with incidence angle. Results show that optimizing probe alignment to within reduces divergence and beam current measurement uncertainty to below 2.5%. These findings highlight diagnostic geometry as a key factor in high-precision plume characterization.
  • Item type:Item,
    Skeletal effects of JAK1/2 inhibition versus IL-6 receptor blockade in rheumatoid arthritis: a post hoc comparative cohort analysis based on two prospective observational studies
    (2026) Schulz, Nils; van Wijnen, Pascal; Wilhelmi, Tim; Müller-Ladner, Ulf; Lange, Uwe; Klemm, Philipp
    Introduction: Janus kinase inhibitors (JAKi) are increasingly used in rheumatoid arthritis (RA), yet comparative data on systemic effects beyond joint inflammation remain limited. Because chronic inflammation promotes generalized bone loss and IL-6-driven osteoclastogenesis, we compared the skeletal effects of baricitinib and tocilizumab over 12 months. Methods: We performed an exploratory post hoc comparative cohort analysis based on two prospective single-center observational cohorts with harmonized eligibility criteria and identical endpoints. Patients with active RA initiating either baricitinib (n = 26) or tocilizumab (n = 22) underwent dual-energy X-ray absorptiometry (DXA) at baseline and after 12 months. Primary outcomes were changes in bone mineral density (BMD) at the lumbar spine and femoral neck. Secondary analyses included changes in disease activity (DAS28-CRP) and multivariable models to identify factors associated with BMD change. Results: No significant differences in BMD changes were observed between groups. Mean spine BMD increased by +8.2 mg/cm2 (+0.7%, 95% CI [−12.5.29.0]) with baricitinib and +15.6 mg/cm2 (+1.5%, 95% CI [−24.0.55.0]) with tocilizumab. Femoral BMD remained stable under baricitinib (+7.6 mg/cm2, +0.9%, 95% CI [−11.6.26.8]) but declined non-significantly with tocilizumab (−9.8 mg/cm2, -1.0%, 95% CI [−24.8.5.1]). Multivariable ANCOVA identified change in DAS28-CRP as the only factor significantly associated with spine BMD change (β = −0.36; p = 0.027). Treatment type, glucocorticoid exposure, and autoantibody status were not independently associated with BMD outcomes. Conclusion: JAK1/2 inhibition with baricitinib and IL-6 receptor blockade with tocilizumab showed comparable 12-month effects on lumbar spine and femoral neck BMD. These findings suggest that preservation of bone health in RA is more closely linked to effective suppression of inflammatory activity than to a detectable advantage of one targeted mechanism over the other.
  • Item type:Item,
    Extracellular vesicles from canine mesenchymal stem cells : isolation, characterization and miRNA definition following interleukin-1ß and shockwave treatment
    (2026) Klymiuk, Michele C.; Elashry, Mohamed I.; Heimann, Manuela; Wolf-Hofmann, Kathrin; Schubert-Porth, Susanne; Arnhold, Stefan
    Extracellular vesicles (EVs) have become a key area of research, as scientists study their role in various biological processes. These vesicles appear to play a key role in the use of mesenchymal signaling cells (MSCs, formerly known as mesenchymal stem cells) to treat various diseases, such as osteoarthritis (OA), and other degenerative conditions. In our experiments, we examined EVs formed by canine mesenchymal signaling cells (MSCs) to identify them according to current guidelines and define their content, particularly the microRNA (miRNA) they contain, for future research projects. After obtaining the EVs, we demonstrated via Western blotting and transmission electron microscopy that the nanoparticles visible in the nanotracking analysis were positive for CD9 and ALIX and positive for CD9 and CD81, respectively. Markers for nanoparticles that do not represent extracellular particles—tested here as cytochrome C for mitochondrial particles and histones for nuclear particles—were negative. Finally, we detected a total of 85 different miRNAs in the negative controls. To determine the potential influence of various cell stimulations intended to induce osteoarthritis (e.g., interleukin-1β stimulation) or a possible treatment (e.g., shockwave therapy), or the influence of ITS prior to extracellular vesicle extraction, we detected a total of 208 different miRNAs. These results demonstrate how canine EVs from MSCs can be detected in vitro and how the EVs’ miRNA profile changes after stimulation of the producing cells. This information may provide valuable insight into the understanding and treatment of osteoarthritis. Additionally, we demonstrated that using ITS instead of FCS to produce EVs should be reconsidered due to the significant change in miRNA expression levels.
  • Item type:Item,
    Comparative evaluation of staining techniques in thawed cryopreserved dog semen
    (2026) Klumb, Indra Sara; Wehrend, Axel; Farshad, Abbas
    Background: Accurate assessment of sperm morphology is essential for evaluating the quality of cryopreserved canine semen used in artificial insemination and for improving cryopreservation protocols. This study compared six staining techniques, Eosin, Eosin–Nigrosin, Diff-Quick®, Hemacolor®, Spermac®, and Formol-citrate Bengal Rose, for light-microscopic evaluation of frozen–thawed canine spermatozoa. Methods: Semen from ten dogs was thawed, divided into four aliquots, and either left untreated or exposed to thermal stress at 6 °C, 18 °C, or 37 °C for two hours to induce morphological variation. A total of 360 slides and 960 evaluations were performed immediately after staining and again after 24 h, 7 days, and 3 months to assess staining quality and stability over time. Results: Eosin produced stable staining for up to three months and was the most economical method, though its initial detail recognition was lower than that of Spermac® and Formol-citrate Bengal Rose. Eosin–Nigrosin showed reduced contrast and detail. Diff-Quick® provided better contrast than Eosin–Nigrosin, while Hemacolor® maintained consistent quality regardless of stress treatment or storage duration. Spermac® yielded the highest initial morphological detail but deteriorated during storage. Formol-citrate Bengal Rose combined high detail recognition with stable staining throughout the study. Cryopreservation increased looped tails, and incubation at 37 °C markedly elevated pathological sperm and rudimentary tails. Conclusions: All six staining methods were suitable for evaluating and archiving frozen–thawed canine semen. Formol-citrate Bengal Rose and Spermac® offered the best detail, while Eosin provided a cost-effective option with excellent long-term stability.
  • Item type:Item,
    Stepwise translational validation of the screening hit desipramine reveals limits of fibroblast-state modulation in lung fibrosis
    (2026) Panagiotidis, Georgios-Dimitrios; Rivetti, Stefano; Marega, Manuela; Noori, Afshin; El Agha, Elie; Wygrecka, Malgorzata; Braubach, Peter; Klima, Raffaella; Braga, Luca; Bellusci, Saverio